|
Aug 11
|
HAE Q2 Deep Dive: Margin Expansion Amid Revenue Decline and Product Execution Challenges
|
|
Aug 11
|
Arm initiated, Adobe downgraded: Wall Street's top analyst calls
|
|
Aug 11
|
Understanding Haemonetics (HAE) Reliance on International Revenue
|
|
Aug 7
|
Haemonetics (NYSE:HAE) Surprises With Strong Q2 But Stock Drops 24%
|
|
Aug 7
|
Haemonetics (HAE) Reports Q1 Earnings: What Key Metrics Have to Say
|
|
Aug 7
|
Haemonetics (HAE) Q1 Earnings and Revenues Surpass Estimates
|
|
Aug 7
|
Haemonetics: Fiscal Q1 Earnings Snapshot
|
|
Aug 7
|
Haemonetics 1st Quarter Fiscal Year 2026 Earnings Release Available on Investor Relations Website
|
|
Aug 6
|
Unlocking Q1 Potential of Haemonetics (HAE): Exploring Wall Street Estimates for Key Metrics
|
|
Aug 6
|
Haemonetics (HAE) To Report Earnings Tomorrow: Here Is What To Expect
|
|
Jul 31
|
Analysts Estimate Haemonetics (HAE) to Report a Decline in Earnings: What to Look Out for
|
|
Jul 27
|
Haemonetics Builds Momentum with New Buy Rating and Growth Promise
|
|
Jul 23
|
Boston Scientific (BSX) Q2 Earnings and Revenues Surpass Estimates
|
|
Jul 11
|
Lantheus, ICU Medical, Haemonetics, CONMED, and Astrana Health Shares Plummet, What You Need To Know
|
|
Jul 10
|
Integer Appoints Michael Coyle to Board of Directors
|
|
Jul 10
|
Unpacking Q1 Earnings: Haemonetics (NYSE:HAE) In The Context Of Other Medical Devices & Supplies - Specialty Stocks
|
|
Jul 9
|
Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2026 Results: August 7, 2025
|
|
Jun 27
|
5 Must-Read Analyst Questions From Haemonetics’s Q1 Earnings Call
|
|
Jun 23
|
The past five years for Haemonetics (NYSE:HAE) investors has not been profitable
|
|
Jun 9
|
3 Russell 2000 Stocks Skating on Thin Ice
|